Medicus Pharma Ltd. Warrant
MDCXW$0.81 -0.03 (-4.16%)
Company News
Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers
Medicus Pharma is developing innovative treatments for prostate and skin cancers, including a dissolvable microneedle patch for basal cell carcinoma and a next-generation hormone deprivation therapy with reduced cardiovascular risks.
